Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions
Mov Disord
.
2000 May;15(3):439-45.
doi: 10.1002/1531-8257(200005)15:3<439::AID-MDS1004>3.0.CO;2-F.
Authors
A D Siderowf
1
,
R G Holloway
,
M B Stern
Affiliation
1
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia 19107, USA.
PMID:
10830407
DOI:
10.1002/1531-8257(200005)15:3<439::AID-MDS1004>3.0.CO;2-F
No abstract available
Publication types
Review
MeSH terms
Clinical Trials as Topic
Cost-Benefit Analysis
Humans
Parkinson Disease / economics*
Parkinson Disease / therapy
Quality-Adjusted Life Years
Technology Assessment, Biomedical / economics